Choose a TMS provider in Brooklyn or anywhere in New York City the way you would choose a surgeon: by who is responsible for your care, what they use, how they measure results, and how they handle safety and insurance. Location matters, but for a treatment you attend daily for weeks, the quality of medical oversight and honest communication matter more.
The checklist below works for any clinic. It is built around questions you can ask on a phone call or at a consultation, and each criterion explains what a good answer sounds like and why.
1. A psychiatrist who is actually involved
TMS is a medical treatment ordered by a physician or, in some plans, a qualified psychiatric nurse practitioner. The American Psychiatric Association's 2024 position statement describes TMS as safe and effective "when administered by TMS-trained psychiatrists for appropriately selected patients." Insurers set supervision rules too. New York Medicare's policy requires treatment under the direct supervision of a physician who is present in the area, and an August 2026 revision made clear that this must be an MD or DO.
Ask who evaluates you, who sets your dose, who reviews your progress, and who is on site during sessions. Technicians usually run day-to-day sessions, which is normal; the question is whether a psychiatrist sees you at the start, checks in during the course, and is reachable if something changes. The physician-level article on who delivers TMS and why oversight matters goes deeper.
2. FDA-cleared equipment and a clear protocol
All TMS devices are "FDA-cleared" rather than "FDA-approved"; none holds the premarket approval used for higher-risk devices. A clinic should be able to tell you which device it uses and what it is cleared for. Is TMS FDA-approved? explains the difference and lists cleared uses.
Then ask which protocol they would recommend for you, and why. Common options include:
- Standard 10 Hz rTMS: the NeuroStar label describes five sessions a week for six weeks plus a three-week taper, 36 sessions in all. Session length depends on settings and can be as short as about 19 minutes.
- Intermittent theta burst (iTBS): a session of about three minutes, cleared in 2018 on the strength of the THREE-D trial, which found it non-inferior to 10 Hz.
- Accelerated protocols: several sessions per day. More than one accelerated protocol is now FDA-cleared, including SAINT and newer systems from other manufacturers.
A good answer explains the trade-offs for you specifically, including cost and coverage. Many insurers still treat accelerated protocols as experimental; Aetna and Cigna each list them as experimental, and Optum lists them as unproven. See is accelerated TMS covered by insurance? before committing. For device-level detail, the TMS devices comparison is a useful reference.
Be cautious about protocols marketed as one-day cures combined with medications. The Clinical TMS Society has stated that the single-day ONE-D protocol was not FDA-cleared and that its evidence does not meet the threshold to recommend it over better-studied approaches.
3. How they find the treatment spot
Every course starts with "mapping": finding your motor threshold to set the dose, then locating the treatment target. The SAINT device summary, for example, describes motor threshold set by visual inspection of finger movement plus EMG. Clinics use different targeting methods. The older "5 cm rule" was shown in a small 2001 neuronavigation study to miss the intended area in 15 of 22 people. A 2023 randomized trial found the Beam F3 measurement method and a 5.5 cm method gave similar results.
You do not need to become an expert. Ask how they locate the target, whether they re-check your motor threshold during the course, and what they do if you are not improving. The first TMS session: mapping, motor threshold and dose explains the process from the chair.
4. Measurement you can see
A well-run course measures symptoms on a validated scale at the start, during, and at the end. New York Medicare requires validated scales such as the PHQ-9, HAM-D or MADRS to monitor response, and Cigna requires scores at the beginning and end of each course. Ask how often you will be rated, whether you will see your scores, and what change would prompt a discussion about adjusting treatment. Clinics that share your numbers make it easier for you to judge progress and to qualify for a repeat course later if you need one.
5. Honest talk about results
Be wary of a single headline success rate. Open-label and registry figures in the range of 58% to 83% response are mostly self-reported, come from voluntarily reporting sites, and are not comparable with sham-controlled trial results. In randomized trials, the gap in remission between active and sham TMS is typically about 9 to 18 percentage points. A trustworthy provider will describe benefit as a real chance, not a promise, and will tell you what happens if the first course does not help.
6. A clear safety process
TMS is generally well tolerated, but safety screening is not optional. Look for:
- A written screening questionnaire covering metal or implants in or near the head, implanted devices, seizure history and medications.
- Hearing protection at every session. FDA guidance asks that patients and operators always wear earplugs or similar protection rated for 30 dB of noise reduction.
- A seizure response plan. Seizures are rare, but they are most likely within the first few exposures to TMS, and staff should know how to respond.
- Instructions about sleep, alcohol and new medications, since sleep deprivation and alcohol are among the factors that can lower seizure threshold.
7. Insurance handled in the open
Coverage rules vary widely by plan, and many plans require prior authorization or a medical-necessity review. A good clinic will verify your benefits, explain what your plan requires, tell you who submits the paperwork, and give you an estimate in writing before you start. If you are paying yourself, federal rules entitle you to a Good Faith Estimate when you schedule care in advance or ask for one. Ask whether maintenance sessions or a re-mapping would cost extra. Does insurance cover TMS? walks through the New York picture.
8. A schedule you can keep, and care that connects
Daily sessions for weeks are the biggest practical hurdle. Ask about available hours, how missed sessions are handled, and whether the location is realistic for your commute; getting to daily TMS sessions in Brooklyn covers transit and timing. Then ask how the TMS team works with your current psychiatrist and therapist. TMS sits best inside a wider plan that includes medication decisions and therapy, which is the focus of TMS within integrative psychiatry.
Advertising claims worth questioning
TMS is marketed heavily in New York, and some advertising runs ahead of the evidence. A few phrases deserve a follow-up question:
- "No side effects." Scalp discomfort and headache are common, and seizure is a rare but labeled risk. An accurate description is that side effects are usually mild and temporary.
- "Permanent results." In studies, roughly half to about 6 in 10 of the people who responded were still doing well at one year, and claims of permanence are overstated. Life after TMS covers what to plan for.
- "Works for anxiety, PTSD, ADHD..." Some devices carry clearances beyond depression, such as obsessive-compulsive disorder, and one system was cleared in June 2026 as an add-on treatment for PTSD in adults, but many advertised uses, ADHD among them, are off-label or research-stage. Ask which cleared indication applies to you.
- "Done in a week." Some accelerated schedules really are compressed, but at least one cleared accelerated protocol runs over six weeks including follow-up sessions. Ask for the full calendar.
Brooklyn and NYC practicalities
A few things are specific to choosing care in the city. Many New Yorkers have plans administered by a separate behavioral health company, so the name on your card may not be the company that reviews TMS requests; ask the clinic to confirm who manages your behavioral health benefits. If your plan's network cannot offer a timely behavioral health appointment, New York rules that took effect on July 1, 2025 require insurers to allow out-of-network care at in-network cost-sharing when the network cannot meet its appointment timeframes. That rule concerns appointment access generally, so ask your plan how it applies before assuming it covers a TMS course.
Finally, think about the whole six weeks, not just the first visit. A clinic near your workplace may suit a weekday routine better than one near home. If you see a psychiatrist and therapist already, a TMS team that communicates with them easily can save you from repeating your history and keeps medication decisions coordinated.
A one-page checklist for your calls
| Ask | A reassuring answer | A reason to pause |
|---|---|---|
| Who oversees my treatment? | A named psychiatrist evaluates me and reviews my progress | No one can say who the supervising physician is |
| Which device and protocol? | A named FDA-cleared device and a reason for the protocol | "FDA-approved" claims or a one-size-fits-all package |
| How do you find the target? | A clear method and a plan if I'm not improving | Vague answers |
| How will we track progress? | Regular validated scales that I can see | No routine measurement |
| What results should I expect? | Ranges, uncertainty, and a plan B | A single high success rate or a guarantee |
| What does my plan require? | A benefits check and written estimate before starting | Pressure to pay upfront before verification |
| How do you work with my other clinicians? | Records shared with my consent | TMS treated as stand-alone |
Bring the practice's own list of questions to ask about TMS therapy as well, and see what to expect at a TMS consultation. The full TMS guide covers every step, and the TMS therapy page explains how to ask about a consultation in Brooklyn.
Sources
- Position Statement on Transcranial Magnetic Stimulation (TMS). American Psychiatric Association, 2024. psychiatry.org
- LCD L33398 Transcranial Magnetic Stimulation (version 40). Wellpoint Federal via CMS Medicare Coverage Database, 2026. cms.gov
- Premarket Notification 510(k). U.S. Food and Drug Administration, 2026. fda.gov
- 510(k) Summary K231926: NeuroStar Advanced Therapy System. U.S. Food and Drug Administration, 2024. accessdata.fda.gov
- 510(k) Summary K173620: MagVita TMS Therapy System w/Theta Burst Stimulation. U.S. Food and Drug Administration, 2018. accessdata.fda.gov
- Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial. The Lancet, 2018. pubmed.ncbi.nlm.nih.gov
- 510(k) Summary K260189: MagVenture Accelerated TMS (aTMS) Therapy System. U.S. Food and Drug Administration, 2026. accessdata.fda.gov
- Transcranial Magnetic Stimulation and Cranial Electrical Stimulation (Clinical Policy Bulletin 0469). Aetna, 2026. aetna.com
- Transcranial Magnetic Stimulation (Coverage Policy EN0383). Evernorth Health Services (Cigna), 2026. a.static.cigna.com
- Behavioral Clinical Policy: Transcranial Magnetic Stimulation (BH803TMS112025). Optum Behavioral Health Solutions, 2026. providerexpress.com
- Clinical TMS Society's Statement on Level of Evidence for Single-Day TMS combined with Medications. Clinical TMS Society, 2025. clinicaltmssociety.org
- 510(k) Summary K220177: Magnus Neuromodulation System with SAINT Technology. U.S. Food and Drug Administration, 2022. accessdata.fda.gov
- Transcranial magnetic stimulation in therapy studies: examination of the reliability of 'standard' coil positioning by neuronavigation. Biological Psychiatry, 2001. pubmed.ncbi.nlm.nih.gov
- A randomized trial comparing beam F3 and 5.5 cm targeting in rTMS treatment of depression demonstrates similar effectiveness. Brain Stimulation, 2023. pubmed.ncbi.nlm.nih.gov
- Billing and Coding: Transcranial Magnetic Stimulation (A57528). Wellpoint Federal via CMS Medicare Coverage Database, 2026. cms.gov
- Clinical outcomes in a large registry of patients with major depressive disorder treated with Transcranial Magnetic Stimulation. Journal of Affective Disorders, 2020. pubmed.ncbi.nlm.nih.gov
- Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Archives of General Psychiatry, 2010. pubmed.ncbi.nlm.nih.gov
- Class II Special Controls Guidance Document: Repetitive Transcranial Magnetic Stimulation (rTMS) Systems. U.S. Food and Drug Administration, 2011. fda.gov
- Seizures from transcranial magnetic stimulation 2012-2016: Results of a survey of active laboratories and clinics. Clinical Neurophysiology, 2019. europepmc.org
- Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines. Clinical Neurophysiology, 2021. europepmc.org
- Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. Journal of Clinical Psychiatry, 2008. europepmc.org
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults. Canadian Journal of Psychiatry, 2024. pmc.ncbi.nlm.nih.gov
- 510(k) Summary K251449: BrainsWay accelerated Deep TMS protocol. U.S. Food and Drug Administration, 2025. accessdata.fda.gov
- DFS press release: network adequacy and access standards for behavioral health. New York Department of Financial Services, 2025. dfs.ny.gov
- Good faith estimate (No Surprises Act consumer guide). Centers for Medicare & Medicaid Services, 2026. cms.gov
FAQs
Does it matter whether a psychiatrist or a technician gives the sessions?
Trained technicians commonly run daily sessions. What matters is that a psychiatrist evaluates you, sets and reviews the treatment plan, and supervises as your insurer and the device labeling require.
Is a newer TMS device always better?
Not necessarily. Several protocols have good evidence, and the right one depends on your history, schedule and coverage. Ask why a particular protocol is being recommended for you.
Should I choose the TMS clinic closest to home?
Proximity helps because sessions are daily, but oversight, measurement and insurance handling matter more. A slightly longer trip to a well-run program is often worth it.
What if a clinic quotes a very high success rate?
Ask where the number comes from. Registry and open-label figures are usually much higher than results from sham-controlled trials and should not be read as your personal odds.
Can I switch TMS providers partway through a course?
It is possible but can complicate dosing and insurance authorization. Raise concerns with the supervising psychiatrist first, and if you do switch, ask for your mapping records and scores to be sent.
